Old Web
English
Sign In
Acemap
>
authorDetail
>
Douglas Chung
Douglas Chung
Medicine
Pharmacology
Immunology
Gene expression
Prostate cancer
4
Papers
8
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Quantitative Systems Pharmacology (QSP) Model to Compare the Non-Clinical Biodistribution and Efficacy between Recombinant Factor IX (rIX) Therapies
2021
Blood
Sabine Pestel
Douglas Chung
Alireza Rezvani-Sharif
Ineke L. Muir
Sivarmurthy Krupa
Markus Brechmann
Anne M. Verhagen
Steve K. Dower
Piet H. van der Graaf
Eva Herzog
Oliver Ghobrial
Show All
Source
Cite
Save
Citations (0)
Modeling shows the NK3R antagonist, ACER-801, reduces treatment-induced vasomotor symptoms.
2021
Journal of Clinical Oncology
Rebecca Baillie
Chris Schelling
Rick Ridgewell
Katherine Kudrycki
Douglas Chung
Christina M. Friedrich
Michael F. Reed
Show All
Source
Cite
Save
Citations (0)
Abstract 3983: A cross comparison of technologies for the detection of immune system related gene expression signatures in clinical FFPE samples of metastatic prostate cancer patients
2017
Cancer Research
Kimberly Kruse
Fang-Yin Lo
Ryan Fleming
Douglas Chung
Vickie Satele
Lindsey Maassel
Tuuli Saloranta
Inah Golez
Saman Tahir
Sally Dow
Evan Anderson
Spencer Chee
Raghavee Venkatramanan
Steve Anderson
Peter S. Nelson
Colm Morrissey
Anup Madan
Sharon Austin
Kellie Howard
Show All
Source
Cite
Save
Citations (0)
Next generation patient monitor powered by in-silico physiology.
2015
EMBC | International Conference of the IEEE Engineering in Medicine and Biology Society
Dimitar Baronov
Michael McManus
Evan J. Butler
Douglas Chung
Melvin C. Almodovar
Show All
Source
Cite
Save
Citations (8)
1